• Issue

    Clinical & Experimental Allergy: Volume 54, Issue 1

    1-85
    January 2024

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1-3
  • First Published: 17 January 2024

REVIEW ARTICLE

Open Access

Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps

  • Pages: 11-20
  • First Published: 02 January 2024
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps

Perioperative anaphylaxis is a severe condition but mortality is rare, mainly due to neuromuscular blocking agents and antibiotics. Pathophysiology of fatal cases is not completely known. Timely administration of adrenaline and fluid therapy are crucial but there is no consensus on the ideal algorithm to manage severe perioperative anaphylaxis.

ORIGINAL ARTICLES

Open Access

Glycolysis: An early marker for vancomycin-specific T-cell activation

  • Pages: 21-33
  • First Published: 04 January 2024
Glycolysis: An early marker for vancomycin-specific T-cell activation

Vancomycin has been linked with drug reaction with DRESS in HLA-A*32:01 expressing individuals and is associated with activation of drug-specific T lymphocytes. However, the metabolic processes than underpin drug-reactive T-cell activation are undefined. CD4+ and CD8+ vancomycin-specific T-cell clones (TCCs) generated from healthy donors and hypersensitive patients expressing HLA-A*32:01 undergo dose-dependent, drug-specific and HLA restricted glycolytic switching when activated with vancomycin. TCCs displayed ‘energetic’ cross-reactivity with teicoplanin, indicating the master switch for T-cell activation may be located upstream of metabolic signalling.

Open Access

Egg-sensitised infants have elevated CD4+ effector memory T regulatory cells from birth

  • Pages: 34-45
  • First Published: 02 January 2024
Egg-sensitised infants have elevated CD4+ effector memory T regulatory cells from birth

IgE-mediated sensitisation to egg is common in infants but the underlying mechanisms remain poorly understood. We identified different immunephenotypes between the infants who were IgE-egg sensitised and not-IgE-egg sensitised. Immunological profiles associated with egg sensitisation are detectable at 4–6 months-old and even at birth.

Free Access

Design of an Ara h 2 hypoallergen from conformational epitopes

  • Pages: 46-55
  • First Published: 02 January 2024
Design of an Ara h 2 hypoallergen from conformational epitopes

Ara h 2 structure determined in complex with human antibodies. Hypoallergen engineered for reduced IgE binding. Hypoallergen demonstrates reduced anaphylaxis in mice primed with peanut allergic serum.

RESEARCH LETTERS